Close Menu

NEW YORK (360Dx) – Q BioMed said today that it has exercised its option to exclusively license the biomarker, growth differentiation factor 15 (GDF15), from Washington University in St. Louis for determining the severity of glaucoma.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.